SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000936392-02-000416
Filing Date
2002-04-11
Accepted
2002-04-11 00:00:00
Documents
5
Period of Report
2002-05-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a80508ddef14a.htm DEF 14A 378184
3 GRAPHIC a80508da80508l1.gif GRAPHIC 1159
4 GRAPHIC a80508da80508s1.gif GRAPHIC 2771
5 GRAPHIC a80508da80508g1.gif GRAPHIC 12257
6 GRAPHIC a80508dbox.gif GRAPHIC 1220
  Complete submission text file 0000936392-02-000416.txt   397525
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 02608336
SIC: 2836 Biological Products, (No Diagnostic Substances)